MDxHealth SA
MDXH
$0.55
-$0.02-2.78%
NASDAQ
| 12/31/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 94.51M | 90.05M | 84.71M | 80.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 94.51M | 90.05M | 84.71M | 80.74M |
| Cost of Revenue | -- | 35.93M | 34.91M | 32.41M | 30.17M |
| Gross Profit | -- | 58.58M | 55.14M | 52.30M | 50.57M |
| SG&A Expenses | -- | 64.06M | 63.78M | 63.43M | 61.51M |
| Depreciation & Amortization | -- | 5.10M | 4.91M | 8.07M | 7.87M |
| Other Operating Expenses | -- | 998.00K | 381.00K | -253.00K | -254.00K |
| Total Operating Expenses | -- | 116.97M | 114.53M | 110.89M | 105.39M |
| Operating Income | -- | -22.46M | -24.48M | -26.18M | -24.65M |
| Income Before Tax | -- | -38.24M | -37.68M | -41.60M | -40.80M |
| Income Tax Expenses | -- | 529.00K | 392.00K | 345.00K | 1.00K |
| Earnings from Continuing Operations | -- | -38.77 | -38.07 | -41.95 | -40.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -38.77M | -38.07M | -41.95M | -40.80M |
| EBIT | -- | -22.46M | -24.48M | -26.18M | -24.65M |
| EBITDA | -- | -14.08M | -16.44M | -18.75M | -17.50M |
| EPS Basic | -- | -1.15 | -1.27 | -1.52 | -1.49 |
| Normalized Basic EPS | -- | -0.16 | -0.16 | -0.20 | -0.20 |
| EPS Diluted | -- | -1.15 | -1.27 | -1.52 | -1.49 |
| Normalized Diluted EPS | -- | -0.16 | -0.16 | -0.20 | -0.20 |
| Average Basic Shares Outstanding | -- | 152.75M | 131.74M | 110.36M | 109.54M |
| Average Diluted Shares Outstanding | -- | 152.75M | 131.74M | 110.36M | 109.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |